These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 7998821)

  • 21. Effect of 25-hydroxycholesterol on cytotoxicity and prostacyclin production in cultured human umbilical arterial endothelial cells.
    Kawamura K; Kummerow FA
    Eicosanoids; 1992; 5(1):29-34. PubMed ID: 1419077
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cadmium attenuates bradykinin-driven nitric oxide production by interplaying with the localization pattern of endothelial nitric oxide synthase.
    Majumder S; Gupta R; Reddy H; Sinha S; Muley A; Kolluru GK; Chatterjee S
    Biochem Cell Biol; 2009 Aug; 87(4):605-20. PubMed ID: 19767824
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparative pharmacology of endothelium-derived relaxing factor, nitric oxide and prostacyclin in platelets.
    Radomski MW; Palmer RM; Moncada S
    Br J Pharmacol; 1987 Sep; 92(1):181-7. PubMed ID: 3311265
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Platelet inhibition by endothelium-derived relaxing factor from the rabbit perfused aorta.
    Bult H; Fret HR; Van den Bossche RM; Herman AG
    Br J Pharmacol; 1988 Dec; 95(4):1308-14. PubMed ID: 3064856
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of free fatty acids found increased in women who develop pre-eclampsia on the ability of endothelial cells to produce prostacyclin, cGMP and inhibit platelet aggregation.
    Endresen MJ; Tøsti E; Heimli H; Lorentzen B; Henriksen T
    Scand J Clin Lab Invest; 1994 Nov; 54(7):549-57. PubMed ID: 7863232
    [TBL] [Abstract][Full Text] [Related]  

  • 26. SK&F 96365 inhibits histamine-induced formation of endothelium-derived relaxing factor in human endothelial cells.
    Graier WF; Groschner K; Schmidt K; Kukovetz WR
    Biochem Biophys Res Commun; 1992 Aug; 186(3):1539-45. PubMed ID: 1510680
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Impaired EDRF production by endothelial cells exposed to fibrin monomer and FDP.
    Freedman JE; Fabian A; Loscalzo J
    Am J Physiol; 1995 Feb; 268(2 Pt 1):C520-6. PubMed ID: 7532361
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The anti-aggregating properties of vascular endothelium: interactions between prostacyclin and nitric oxide.
    Radomski MW; Palmer RM; Moncada S
    Br J Pharmacol; 1987 Nov; 92(3):639-46. PubMed ID: 3322462
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Discrepancy between the nephrotoxic potencies of cadmium-metallothionein and cadmium chloride and the renal concentration of cadmium in the proximal convoluted tubules.
    Dorian C; Gattone VH; Klaassen CD
    Toxicol Appl Pharmacol; 1995 Jan; 130(1):161-8. PubMed ID: 7839364
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Endothelium-derived relaxing factor modulates the atherothrombogenic effects of homocysteine.
    Stamler JS; Loscalzo J
    J Cardiovasc Pharmacol; 1992; 20 Suppl 12():S202-4. PubMed ID: 1282970
    [TBL] [Abstract][Full Text] [Related]  

  • 31. N-acetylcysteine potentiates platelet inhibition by endothelium-derived relaxing factor.
    Stamler J; Mendelsohn ME; Amarante P; Smick D; Andon N; Davies PF; Cooke JP; Loscalzo J
    Circ Res; 1989 Sep; 65(3):789-95. PubMed ID: 2548765
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Potentiation of anti-platelet aggregating activity of cilostazol with vascular endothelial cells.
    Igawa T; Tani T; Chijiwa T; Shiragiku T; Shimidzu S; Kawamura K; Kato S; Unemi F; Kimura Y
    Thromb Res; 1990 Feb; 57(4):617-23. PubMed ID: 2158154
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Endothelium-derived relaxing factor inhibits in vitro platelet aggregation.
    Furlong B; Henderson AH; Lewis MJ; Smith JA
    Br J Pharmacol; 1987 Apr; 90(4):687-92. PubMed ID: 3495310
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Adverse vascular effects of homocysteine are modulated by endothelium-derived relaxing factor and related oxides of nitrogen.
    Stamler JS; Osborne JA; Jaraki O; Rabbani LE; Mullins M; Singel D; Loscalzo J
    J Clin Invest; 1993 Jan; 91(1):308-18. PubMed ID: 8380812
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of CdCl2 and Cd-metallothionein on cultured mesangial cells.
    Chin TA; Templeton DM
    Toxicol Appl Pharmacol; 1992 Sep; 116(1):133-41. PubMed ID: 1529446
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Characterization and actions of human umbilical endothelium derived relaxing factor.
    Chaudhuri G; Buga GM; Gold ME; Wood KS; Ignarro LJ
    Br J Pharmacol; 1991 Feb; 102(2):331-6. PubMed ID: 1849765
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prostaglandin E1 at clinically relevant concentrations inhibits aggregation of platelets under synergic interaction with endothelial cells.
    Koga T; Az-ma T; Yuge O
    Acta Anaesthesiol Scand; 2002 Sep; 46(8):987-93. PubMed ID: 12190800
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Endothelium-derived relaxant factor inhibits platelet activation.
    Busse R; Lückhoff A; Bassenge E
    Naunyn Schmiedebergs Arch Pharmacol; 1987 Nov; 336(5):566-71. PubMed ID: 2830546
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of cadmium on the monolayer maintenance of vascular endothelial cells in culture.
    Kaji T; Mishima A; Yamamoto C; Sakamoto M; Koizumi F
    Toxicology; 1992; 71(3):267-76. PubMed ID: 1736418
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Differential control and calcium-dependence of production of endothelium-derived relaxing factor and prostacyclin by pig aortic endothelial cells.
    White DG; Martin W
    Br J Pharmacol; 1989 Jul; 97(3):683-90. PubMed ID: 2547481
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.